Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
Price:
6.97
CNY
1.6%
Market Closed
Market Cap:
¥3.4B
Balance Sheet
Balance Sheet Decomposition
Guangdong VTR Bio-Tech Co Ltd
Guangdong VTR Bio-Tech Co Ltd
Balance Sheet Decomposition is not available for
Guangdong VTR Bio-Tech Co Ltd
Guangdong VTR Bio-Tech Co Ltd
Balance Sheet
Guangdong VTR Bio-Tech Co Ltd
Guangdong VTR Bio-Tech Co Ltd
Currency: CNY
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
51
|
81
|
82
|
91
|
110
|
162
|
229
|
188
|
873
|
165
|
257
|
252
|
823
|
252
|
288
|
|
| Cash |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
252
|
6
|
252
|
288
|
|
| Cash Equivalents |
50
|
80
|
81
|
90
|
108
|
161
|
228
|
188
|
873
|
165
|
256
|
0
|
816
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
689
|
881
|
504
|
|
| Total Receivables |
56
|
51
|
57
|
68
|
139
|
314
|
484
|
634
|
592
|
700
|
704
|
667
|
263
|
259
|
279
|
|
| Accounts Receivables |
48
|
46
|
46
|
56
|
133
|
273
|
388
|
540
|
475
|
566
|
586
|
487
|
242
|
222
|
208
|
|
| Other Receivables |
8
|
5
|
11
|
12
|
6
|
41
|
96
|
94
|
116
|
134
|
118
|
180
|
21
|
36
|
70
|
|
| Inventory |
22
|
26
|
31
|
37
|
74
|
431
|
608
|
779
|
1 004
|
1 074
|
1 050
|
992
|
205
|
196
|
195
|
|
| Other Current Assets |
3
|
1
|
2
|
1
|
126
|
35
|
39
|
124
|
118
|
103
|
73
|
41
|
63
|
106
|
18
|
|
| Total Current Assets |
132
|
160
|
171
|
196
|
449
|
942
|
1 360
|
1 724
|
2 587
|
2 042
|
2 083
|
1 952
|
2 043
|
1 695
|
1 283
|
|
| PP&E Net |
83
|
88
|
114
|
169
|
340
|
788
|
963
|
1 188
|
1 327
|
1 557
|
1 624
|
1 625
|
711
|
958
|
1 227
|
|
| PP&E Gross |
0
|
0
|
114
|
169
|
340
|
788
|
963
|
1 188
|
1 327
|
1 557
|
1 624
|
1 625
|
711
|
958
|
1 227
|
|
| Accumulated Depreciation |
0
|
0
|
65
|
75
|
94
|
274
|
356
|
448
|
551
|
670
|
794
|
925
|
513
|
578
|
622
|
|
| Intangible Assets |
12
|
11
|
10
|
10
|
52
|
147
|
212
|
331
|
361
|
366
|
382
|
420
|
262
|
321
|
319
|
|
| Goodwill |
0
|
0
|
0
|
0
|
121
|
508
|
495
|
485
|
477
|
477
|
477
|
396
|
37
|
37
|
37
|
|
| Long-Term Investments |
2
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
7
|
12
|
29
|
26
|
15
|
15
|
7
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
2
|
64
|
177
|
113
|
42
|
65
|
78
|
60
|
105
|
70
|
76
|
|
| Other Assets |
0
|
0
|
0
|
0
|
121
|
508
|
495
|
485
|
477
|
477
|
477
|
396
|
37
|
37
|
37
|
|
| Total Assets |
229
N/A
|
259
+13%
|
296
+14%
|
376
+27%
|
963
+156%
|
2 452
+155%
|
3 210
+31%
|
3 845
+20%
|
4 801
+25%
|
4 518
-6%
|
4 672
+3%
|
4 480
-4%
|
3 172
-29%
|
3 095
-2%
|
2 949
-5%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
25
|
25
|
25
|
32
|
56
|
214
|
158
|
196
|
141
|
289
|
254
|
248
|
69
|
86
|
130
|
|
| Accrued Liabilities |
4
|
8
|
7
|
11
|
9
|
25
|
40
|
33
|
49
|
42
|
47
|
52
|
36
|
36
|
35
|
|
| Short-Term Debt |
29
|
24
|
0
|
0
|
20
|
404
|
478
|
919
|
1 014
|
681
|
796
|
775
|
127
|
121
|
62
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
18
|
44
|
53
|
118
|
63
|
14
|
60
|
0
|
53
|
0
|
|
| Other Current Liabilities |
21
|
6
|
7
|
12
|
49
|
104
|
95
|
193
|
121
|
41
|
34
|
32
|
17
|
14
|
15
|
|
| Total Current Liabilities |
80
|
63
|
38
|
55
|
134
|
765
|
814
|
1 393
|
1 443
|
1 115
|
1 145
|
1 167
|
249
|
309
|
243
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
90
|
161
|
234
|
195
|
767
|
502
|
119
|
127
|
51
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
3
|
25
|
18
|
16
|
21
|
19
|
17
|
16
|
6
|
6
|
5
|
|
| Minority Interest |
1
|
1
|
1
|
1
|
22
|
120
|
155
|
152
|
265
|
264
|
285
|
255
|
110
|
121
|
43
|
|
| Other Liabilities |
5
|
9
|
16
|
16
|
52
|
87
|
90
|
151
|
164
|
153
|
128
|
122
|
50
|
45
|
47
|
|
| Total Liabilities |
85
N/A
|
72
-15%
|
54
-24%
|
71
+31%
|
300
+323%
|
1 156
+285%
|
1 310
+13%
|
1 907
+46%
|
2 659
+39%
|
2 053
-23%
|
1 694
-17%
|
1 687
0%
|
466
-72%
|
480
+3%
|
337
-30%
|
|
| Equity | ||||||||||||||||
| Common Stock |
39
|
39
|
39
|
39
|
100
|
120
|
407
|
407
|
407
|
440
|
490
|
490
|
490
|
490
|
491
|
|
| Retained Earnings |
104
|
147
|
202
|
265
|
297
|
348
|
448
|
504
|
602
|
705
|
838
|
685
|
654
|
595
|
598
|
|
| Additional Paid In Capital |
2
|
2
|
2
|
2
|
267
|
828
|
1 045
|
1 028
|
1 028
|
1 259
|
1 642
|
1 610
|
1 614
|
1 618
|
1 633
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
61
|
100
|
100
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
106
|
62
|
9
|
9
|
9
|
11
|
2
|
|
| Total Equity |
144
N/A
|
187
+30%
|
242
+29%
|
305
+26%
|
663
+117%
|
1 296
+95%
|
1 900
+47%
|
1 939
+2%
|
2 142
+10%
|
2 465
+15%
|
2 978
+21%
|
2 793
-6%
|
2 706
-3%
|
2 615
-3%
|
2 612
0%
|
|
| Total Liabilities & Equity |
229
N/A
|
259
+13%
|
296
+14%
|
376
+27%
|
963
+156%
|
2 452
+155%
|
3 210
+31%
|
3 845
+20%
|
4 801
+25%
|
4 518
-6%
|
4 672
+3%
|
4 480
-4%
|
3 172
-29%
|
3 095
-2%
|
2 949
-5%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
234
|
234
|
234
|
117
|
298
|
360
|
407
|
407
|
407
|
440
|
490
|
490
|
484
|
479
|
480
|
|
Switch to:
Switch to:
See Also
Discover More
